| 089 Desmoglein 2 promotes tumor development through miR-146a/IRAK1/IL-8 signaling axis BL Hill, A Calder, J Flemming, S Gilmore, Y Guo, L Harshyne, ... Journal of Investigative Dermatology 142 (8), S15, 2022 | | 2022 |
| 10: 20: Ultrasound-Guided Sentinel Node Biopsy in a Porcine Model ME Kupferman, JS Rhee, J Curry, EA Bloedon, D Rosen, EA Pribitkin Otolaryngology--Head and Neck Surgery 137 (2_suppl), P77-P77, 2007 | | 2007 |
| 114 Blood-borne exosomes as biomarkers in head and neck squamous cell carcinoma (HNSCC) AN Calder, BL Hill, Y Guo, A Linnenbach, U Martinez-Outschoorn, J Curry, ... Journal of Investigative Dermatology 142 (8), S19, 2022 | | 2022 |
| 173 A role for DACH1 in squamous cell carcinoma M Farshchian, J Hamilton, R Pestell, J Lee, J Curry, J Sahu, TG Webster Journal of Investigative Dermatology 138 (5), S29, 2018 | | 2018 |
| 257 Fibroblasts can mediate partial-epithelial to mesenchymal transition in squamous cell carcinoma keratinocytes in the absence of canonical TGF-beta response P Park, MH Alexander, G Tartaglia, J Curry, A Luginbuhl, AP South Journal of Investigative Dermatology 143 (5), S44, 2023 | | 2023 |
| 3D Modeling of Lacrimal SAC Tumor Growth Patterns TJ Clarke, R Banoub, SH Siddiqui, G D'Souza, V Jegede, M Luo, J Curry Journal of Neurological Surgery Part B: Skull Base 84 (S 01), S186, 2023 | | 2023 |
| 450 Sun exposed individual normal keratinocytes tolerate multiple cancer-causing mutations in vivo A South, M Savarese, I Fuentes, M Prisco, N den Breens, G Kumar, ... Journal of Investigative Dermatology 139 (9), S292, 2019 | | 2019 |
| 490 The effect of Dsg2 in the SSC cells on exosome contents, release, and effects on recipient fibroblasts A Overmiller, J Pierluissi, P Wermuth, U Martinez-Outschoorn, ... Journal of Investigative Dermatology 136 (9), S244, 2016 | | 2016 |
| 4NQO induced carcinogenesis: A mouse model for oral squamous cell carcinoma SH Sagheer, D Whitaker-Menezes, JYS Han, JM Curry, ... Methods in Cell Biology 163, 93-111, 2021 | 21 | 2021 |
| 555 Challenges in predicting ICI response in HPV+ HNSCC: insights into the tumor microenvironment A Nikitina, A Sobol, E Alekseeva, A Tyshevich, A Love, AJ Luginbuhl, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 556 Modeling tumor promoting extracellular matrix dynamics in 3-D suspension culture R Russell, T Webster, M Prisco, D Cognetti, A Luginbuhl, J Curry, ... Journal of Investigative Dermatology 137 (5), S96, 2017 | | 2017 |
| 629-B Window of opportunity for durvalumab plus metformin trial in head & neck squamous cell carcinoma (HNSCC) R Philips, A Alnemri, S Tekumalla, D Mann, H Yang, A Linnenbach, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 2), 2023 | | 2023 |
| 670P Discordant pathologic tumor response in primary tumors and lymph nodes after neoadjuvant immune checkpoint inhibition (ICI) in head and neck squamous cell carcinoma (HNSCC) A Luginbuhl, E Scott, L Harshyne, E Flerova, M Tuluc, S Gargano, ... Annals of Oncology 33, S849, 2022 | | 2022 |
| 672P Nivolumab (Nivo) and ipilimumab (Ipi) combined with radiotherapy (RT) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN … I Vathiotis, JM Johnson, L Harshyne, A Luginbuhl, JM Curry, D Cognetti, ... Annals of Oncology 33, S850, 2022 | 2 | 2022 |
| 689P Effects of durvalumab-metformin on head and neck squamous cell carcinoma (HNSCC) as revealed by digital spatial profiling (DSP) J Riordan, A Linnenbach, A Alnemri, R Philips, S Awosanya, S Sussman, ... Annals of Oncology 33, S858, 2022 | | 2022 |
| 770P Comprehensive immune profiling of primary tumors, lymph nodes, and peripheral blood after treatment with nivolumab and BMS 986205 in head and neck squamous cell carcinoma … L Harshyne, A Linnenbach, M Mahoney, A South, U Martinez-Outschoorn, ... Annals of Oncology 33, S893-S894, 2022 | | 2022 |
| 861MO Spatial distribution of CD8+ and FoxP3+ in a window of opportunity for durvalumab (MEDI4736) plus metformin trial in squamous cell carcinoma of the head and neck (HNSCC) JM Curry, A Alnemri, S Sussman, L Harshyne, A Linnenbach, R Stapp, ... Annals of Oncology 32, S787, 2021 | 1 | 2021 |
| 869P Nivolumab (Nivo) and ipilimumab (Ipi) combined with radiotherapy (RT) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN … JM Johnson, A Ali, E Lorber, D Poller, SW Keith, A Luginbuhl, JM Curry, ... Annals of Oncology 32, S791, 2021 | 1 | 2021 |
| 903 Human cancer-associated fibroblast subsets can predict immune checkpoint response in head and neck cancer patients D Graves, A Obradovic, M Korrer, Y Wang, S Roy, Y Xu, A Luginbuhl, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | | 2021 |
| 923P Immune alterations in a window of opportunity for durvalumab (MEDI4736) plus metformin trial in squamous cell carcinoma of the head and neck (SCCHN) JM Curry, U Nwagu, L Harshyne, A Linnenbach, N Srivastava, ... Annals of Oncology 31, S665-S666, 2020 | 1 | 2020 |
